Business

Add as a preferred source on Google

Eli Lilly Will Acquire Calytrix Bio in Cash Deal Capped at $1.5 Billion

Calytrix Bio is a privately held biotechnology company.

Updated 1 min read
Lilly's corporate campus faces South Delaware Street in downtown Indianapolis, Indiana. / TokenPost.ai (macro)
Lilly's corporate campus faces South Delaware Street in downtown Indianapolis, Indiana. / TokenPost.ai (macro)

Eli Lilly will acquire Calytrix Bio, a privately held biotechnology company, in an all-cash transaction whose maximum stated value for the acquisition is $1.5 billion.

Related articles

View all